{"version":"1.0","type":"rich","provider_name":"Everlit","provider_url":"https://everlit.audio/","title":"MFN pricing is dangerous to drug innovation","description":"Dan Crippen warns MFN drug price controls could slash U.S. pharmaceutical revenues, cut R\u0026D, and stall lifesaving drug development—urging lawmakers to protect innovation while reducing costs.","author_name":"AFRO News","thumbnail_url":"https://cdn.everlit.audio/covers/artl_JK62LsogMkK/defee956-0b83-43af-b6cd-b245ff8f4347/small.webp","width":480,"height":136,"html":"\u003ciframe title=\"MFN pricing is dangerous to drug innovation\" src=\"https://everlit.audio/embeds/artl_JK62LsogMkK\" width=\"100%\" height=\"136px\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen\u003e\u003c/iframe\u003e"}